INS and diabetes mellitus: Patients in the second cohort presented a higher prevalence of diabetes-related conditions, insulin usage, and a greater number of diabetic medications taken, indicating a generally more severe diabetic profile compared with the first cohort (eTable 1 in Supplement 1).